Kabra Drugs Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced operating loss was INR 1.388 million compared to INR 0.109 million a year ago. Net loss was INR 1.388 million compared to INR 0.109 million a year ago. Basic loss per share from continuing operations was INR 0.32 compared to INR 0.02 a year ago. For the full year, net loss was INR 1.8 million compared to INR 0.596 million a year ago. Basic loss per share from continuing operations was INR 0.41 compared to INR 0.14 a year ago.